Testing for antibodies to human aquaporin-4 by ELISA: sensitivity, specificity, and direct comparison with immunohistochemistry.
about
The history of neuromyelitis opticaB Cells in the Multiple Sclerosis Central Nervous System: Trafficking and Contribution to CNS-Compartmentalized InflammationUltrahigh field MRI in clinical neuroimmunology: a potential contribution to improved diagnostics and personalised disease managementMOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome[Ultrahigh field MRI in context of neurological diseases].Neuromyelitis optica: clinical features, immunopathogenesis and treatment.Aquaporin-4 antibodies in patients treated with natalizumab for suspected MS.An immunoassay that distinguishes real neuromyelitis optica signals from a labeling detected in patients receiving natalizumabAquaporin-4 antibody testing: direct comparison of M1-AQP4-DNA-transfected cells with leaky scanning versus M23-AQP4-DNA-transfected cells as antigenic substrate.Screening for MOG-IgG and 27 other anti-glial and anti-neuronal autoantibodies in 'pattern II multiple sclerosis' and brain biopsy findings in a MOG-IgG-positive case.Aquaporin-4 autoantibodies in Neuromyelitis Optica: AQP4 isoform-dependent sensitivity and specificityUpdate on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS).Development of an Aquaporin-4 Orthogonal Array of Particle-Based ELISA for Neuromyelitis Optica Autoantibodies Detection.Epigallocatechin-3-gallate: a useful, effective and safe clinical approach for targeted prevention and individualised treatment of neurological diseases?MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.Evaluation of aquaporin-4 antibody assays.Finding NMO: The Evolving Diagnostic Criteria of Neuromyelitis Optica.Clinical, paraclinical and serological findings in Susac syndrome: an international multicenter study.Aquaporin-4 antibodies (NMO-IgG) as a serological marker of neuromyelitis optica: a critical review of the literature.Characteristics and predictors of progression in an Egyptian multiple sclerosis cohort: a multicenter registry study.The Role of Peripheral CNS-Directed Antibodies in Promoting Inflammatory CNS Demyelination.Aquaporin-4 antibody titration in NMO patients treated with rituximab: A retrospective study.Neuromyelitis optica and myasthenia gravis in a young Nigerian girl[Optical coherence tomography in neuromyelitis optica spectrum disorders].Steroid-responsive hearing impairment in NMO-IgG/aquaporin-4-antibody-positive neuromyelitis optica.Aquaporin 4 antibody [NMO Ab] status in patients with severe optic neuritis in India.Neuromyelitis optica: phenotypic characteristics in a Brazilian case series.Neuromyelitis opticaRituximab-induced hypogammaglobulinemia in patients with neuromyelitis optica spectrum disorders
P2860
Q21245248-D15B526C-0B37-4B79-BD0C-308C603D3859Q26770852-2148EFA0-0F7E-4F12-BD40-7471F8C247CBQ26796643-11EA3C6B-D36E-43B6-B388-DE1DC880EC07Q30371412-5847BC8D-0A83-4E21-B9AD-1ACAFD15F302Q30759627-1EC99C51-2A28-4370-A604-2564977266CEQ30785267-9021DEB5-A90F-4A76-9C29-CC9246B85DD0Q33808279-41A9232E-ADC6-497F-A531-80221FEB9F1EQ33895664-6AD27196-8AD0-4E79-8DD7-2260453F90DEQ34026880-8C5CF8DA-49E2-4D09-B685-C51E3F467695Q34513731-6DC182EC-F5F2-4F8A-92CB-0C31D29D085EQ35048235-1EEB2ED0-A0E6-4D70-A8D2-DE104E029122Q35052199-616516D0-D9AC-42B8-87A3-EEFB1E00BFD7Q35850484-1148FABC-0456-473F-B454-BBCE574A1764Q36648907-3BF97F49-9594-40D9-A838-F8D53F405986Q37374434-6A6A989B-81C3-476A-8D8E-1A87A1063BDFQ37404328-ED9B5D13-7C2B-45B6-91A4-CC789D8D3DDAQ37470003-AB822D87-BF1B-47DA-89F4-89D02C4AACDDQ37717025-B38F47DE-B551-41C2-ACEA-8BB3E53AAF1CQ38151920-68B6A9DF-7F78-4731-9F8F-CA7BEF2E1A0BQ38647849-4CC7BB12-40B5-42A9-8739-1FEFBBC00146Q38714054-E4D8C5C8-AA41-4DC5-ACB9-6AA59148DA8EQ39785941-CEC68A7A-C0B3-4D08-A3BB-624ECB12B4CCQ41890538-DD0A63F1-5E83-4FAE-B06E-0E6102FFD8ABQ50101454-7C6CDE63-1ED1-41A3-A31D-D07B573C0AD5Q50358013-C812E801-E273-49D7-A8D1-FEB9CB522018Q51055303-7C7E7E79-D3F3-448D-933A-395BD42B0D0FQ51127299-7BDCEC54-D482-480D-8535-D193D6F8449CQ56986418-7BF58BC7-E91B-45D1-861F-9194106C57D3Q58742950-894C2765-867B-414F-A06D-8AEA61E5F45C
P2860
Testing for antibodies to human aquaporin-4 by ELISA: sensitivity, specificity, and direct comparison with immunohistochemistry.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Testing for antibodies to huma ...... son with immunohistochemistry.
@en
Testing for antibodies to huma ...... son with immunohistochemistry.
@nl
type
label
Testing for antibodies to huma ...... son with immunohistochemistry.
@en
Testing for antibodies to huma ...... son with immunohistochemistry.
@nl
prefLabel
Testing for antibodies to huma ...... son with immunohistochemistry.
@en
Testing for antibodies to huma ...... son with immunohistochemistry.
@nl
P2093
P1476
Testing for antibodies to huma ...... ison with immunohistochemistry
@en
P2093
B Wildemann
D Franciotta
K Ruprecht
M Ringelstein
P S Rommer
R Bergamaschi
W Kristoferitsch
P356
10.1016/J.JNS.2012.06.002
P577
2012-06-16T00:00:00Z